-
Apr 2006
Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo.
J ImmunolWeber SE, Harbertson J, Godebu E, Mros GA, Padrick RC, Carson BD, Ziegler SF, Bradley LM -
Apr 2006
Allergen-specific MHC class II tetramer+ cells are detectable in allergic, but not in nonallergic, individuals.
J ImmunolMacaubas C, Wahlstrom J, Galvão da Silva AP, Forsthuber TG, Sønderstrup G, Kwok WW, DeKruyff RH, Umetsu DT -
Apr 2006
Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort.
Arthritis RheumKhanna D, Wu H, Park G, Gersuk V, Gold RH, Nepom GT, Wong WK, Sharp JT, Reed EF, Paulus HE, Tsao BP, Western Consortium of Practicing Rheumatologists. -
Apr 2006
Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways.
Arterioscler Thromb Vasc BiolOtsuka G, Agah R, Frutkin AD, Wight TN, Dichek DA -
Apr 2006
Progress, but not yet ready for clinical use: interrupting immune-mediated destruction of pancreatic beta cells in type 1 diabetes.
Curr Diab RepGreenbaum CJ -
Mar 2006
In vivo sites and cellular mechanisms of T reg cell-mediated suppression.
J Exp MedRudensky AY, Campbell DJ -
Mar 2006
Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.
J ImmunolKohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, Kasprowicz DJ, Ziegler SF, Miller SD -
Mar 2006
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
Diabetes CareSosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS -
Mar 2006
Evaluation of leptin levels in subjects at risk for type 1 diabetes.
J AutoimmunGilliam LK, Jensen RA, Yang P, Weigle DS, Greenbaum CJ, Pihoker C -
Mar 2006
Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects.
J ImmunolYang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum CJ, Pihoker C, James EA, Kwok WW -
Mar 2006
Antioxidants inhibit the ability of lysophosphatidylcholine to regulate proteoglycan synthesis.
Arterioscler Thromb Vasc BiolChang MY, Han CY, Wight TN, Chait A -
Mar 2006
Human tissue-engineered blood vessels for adult arterial revascularization.
Nat MedL'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN -
Mar 2006
Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.
ImmunologyReichstetter S, Standifer NE, Geubtner KA, Liu AW, Agar SL, Kwok WW -
Feb 2006
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome.
Proc Natl Acad Sci U S AVarga R, Eriksson M, Erdos MR, Olive M, Harten I, Kolodgie F, Capell BC, Cheng J, Faddah D, Perkins S, Avallone H, San H, Qu X, Ganesh S, Gordon LB, Virmani R, Wight TN, Nabel EG, Collins FS -
Feb 2006
Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury.
Circ ResHuang R, Merrilees MJ, Braun K, Beaumont B, Lemire J, Clowes AW, Hinek A, Wight TN
